Acter (5536) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
10 Jun, 2026Executive summary
Achieved record revenue of NT$11.6 billion and EPS of NT$12.76 in 2026 Q1, with significant YoY growth in all key financial metrics.
Backlog remains at historical highs, supporting future operations and growth.
Core business focuses on electromechanical engineering and cleanroom integration, with a strong presence in the semiconductor ecosystem.
Financial highlights
Operating revenue increased 36% YoY to NT$11.6 billion in 2026 Q1.
Gross profit rose 92% YoY, with gross margin improving from 18% to 25%.
Operating income surged 125% YoY to NT$2.3 billion.
Profit after tax attributable to owners grew 146% YoY to NT$1.58 billion.
EPS reached NT$12.76, up 146% YoY.
Outlook and guidance
High backlog of NT$55 billion+ ensures robust future revenue streams.
Market outlook for cleanroom technology and edge AI remains strong, with global cleanroom market CAGR projected at 5.97% through 2032.
Asia-Pacific identified as the fastest-growing region for cleanroom technology.
Latest events from Acter
- Q1 2024 delivered strong margins, record backlog, robust cash, and a qualified audit review.5536
Q1 202410 Jun 2026 - Record-high revenue and EPS, strong backlog, and improved gross margin at 22%.5536
Q3 202410 Jun 2026 - Record 2024H1 EPS, strong backlog, and top ESG/ROE metrics, with a qualified auditor review.5536
Q2 202410 Jun 2026 - Record revenue, high backlog, and margin gains drive a strong outlook for 2024.5536
Q4 202410 Jun 2026 - Q1 2025 revenue rose 56% with strong net income and backlog, but audit and cash flow risks remain.5536
Q1 202510 Jun 2026 - Record revenue and EPS in 2025H1, with strong backlog and some credit risk concentration.5536
Q2 202510 Jun 2026 - Record revenue and EPS in 2025 Q1–Q3, with strong backlog and ongoing legal and credit risks.5536
Q3 202510 Jun 2026 - Record revenue, strong backlog, and high ROE drive growth and sustained high dividends.5536
Q4 202510 Jun 2026